Assessment of hemodynamic indices of conjunctival microvascular function in patients with coronary microvascular dysfunction
Copyright © 2023 Elsevier Inc. All rights reserved..
OBJECTIVE: Coronary microvascular dysfunction (CMD) is a cause of ischaemia with non-obstructive coronary arteries (INOCA). It is notoriously underdiagnosed due to the need for invasive microvascular function testing. We hypothesized that systemic microvascular dysfunction could be demonstrated non-invasively in the microcirculation of the bulbar conjunctiva in patients with CMD.
METHODS: Patients undergoing coronary angiography for the investigation of chest pain or dyspnoea, with physiologically insignificant epicardial disease (fractional flow reserve ≥0.80) were recruited. All patients underwent invasive coronary microvascular function testing. We compared a cohort of patients with evidence of CMD (IMR ≥25 or CFR <2.0); to a group of controls (IMR <25 and CFR ≥2.0). Conjunctival imaging was performed using a previously validated combination of a smartphone and slit-lamp biomicroscope. This technique allows measurement of vessel diameter and other indices of microvascular function by tracking erythrocyte motion.
RESULTS: A total of 111 patients were included (43 CMD and 68 controls). There were no differences in baseline demographics, co-morbidities or epicardial coronary disease severity. The mean number of vessel segments analysed per patient was 21.0 ± 12.8 (3.2 ± 3.5 arterioles and 14.8 ± 10.8 venules). In the CMD cohort, significant reductions were observed in axial/cross-sectional velocity, blood flow, wall shear rate and stress.
CONCLUSION: The changes in microvascular function linked to CMD can be observed non-invasively in the bulbar conjunctiva. Conjunctival vascular imaging may have utility as a non-invasive tool to both diagnose CMD and augment conventional cardiovascular risk assessment.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:147 |
---|---|
Enthalten in: |
Microvascular research - 147(2023) vom: 20. Mai, Seite 104480 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Mailey, Jonathan A [VerfasserIn] |
---|
Links: |
---|
Themen: |
Cardiovascular screening |
---|
Anmerkungen: |
Date Completed 14.03.2023 Date Revised 16.03.2023 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1016/j.mvr.2023.104480 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM352009527 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM352009527 | ||
003 | DE-627 | ||
005 | 20231226052738.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.mvr.2023.104480 |2 doi | |
028 | 5 | 2 | |a pubmed24n1173.xml |
035 | |a (DE-627)NLM352009527 | ||
035 | |a (NLM)36690270 | ||
035 | |a (PII)S0026-2862(23)00006-7 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Mailey, Jonathan A |e verfasserin |4 aut | |
245 | 1 | 0 | |a Assessment of hemodynamic indices of conjunctival microvascular function in patients with coronary microvascular dysfunction |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 14.03.2023 | ||
500 | |a Date Revised 16.03.2023 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2023 Elsevier Inc. All rights reserved. | ||
520 | |a OBJECTIVE: Coronary microvascular dysfunction (CMD) is a cause of ischaemia with non-obstructive coronary arteries (INOCA). It is notoriously underdiagnosed due to the need for invasive microvascular function testing. We hypothesized that systemic microvascular dysfunction could be demonstrated non-invasively in the microcirculation of the bulbar conjunctiva in patients with CMD | ||
520 | |a METHODS: Patients undergoing coronary angiography for the investigation of chest pain or dyspnoea, with physiologically insignificant epicardial disease (fractional flow reserve ≥0.80) were recruited. All patients underwent invasive coronary microvascular function testing. We compared a cohort of patients with evidence of CMD (IMR ≥25 or CFR <2.0); to a group of controls (IMR <25 and CFR ≥2.0). Conjunctival imaging was performed using a previously validated combination of a smartphone and slit-lamp biomicroscope. This technique allows measurement of vessel diameter and other indices of microvascular function by tracking erythrocyte motion | ||
520 | |a RESULTS: A total of 111 patients were included (43 CMD and 68 controls). There were no differences in baseline demographics, co-morbidities or epicardial coronary disease severity. The mean number of vessel segments analysed per patient was 21.0 ± 12.8 (3.2 ± 3.5 arterioles and 14.8 ± 10.8 venules). In the CMD cohort, significant reductions were observed in axial/cross-sectional velocity, blood flow, wall shear rate and stress | ||
520 | |a CONCLUSION: The changes in microvascular function linked to CMD can be observed non-invasively in the bulbar conjunctiva. Conjunctival vascular imaging may have utility as a non-invasive tool to both diagnose CMD and augment conventional cardiovascular risk assessment | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Cardiovascular screening | |
650 | 4 | |a Conjunctiva | |
650 | 4 | |a INOCA | |
650 | 4 | |a Microvascular angina | |
650 | 4 | |a Microvascular dysfunction | |
700 | 1 | |a Moore, Julie S |e verfasserin |4 aut | |
700 | 1 | |a Brennan, Paul F |e verfasserin |4 aut | |
700 | 1 | |a Jing, Min |e verfasserin |4 aut | |
700 | 1 | |a Awuah, Agnes |e verfasserin |4 aut | |
700 | 1 | |a McLaughlin, James A D |e verfasserin |4 aut | |
700 | 1 | |a Nesbit, M Andrew |e verfasserin |4 aut | |
700 | 1 | |a Moore, Tara C B |e verfasserin |4 aut | |
700 | 1 | |a Spence, Mark S |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Microvascular research |d 1969 |g 147(2023) vom: 20. Mai, Seite 104480 |w (DE-627)NLM000033715 |x 1095-9319 |7 nnns |
773 | 1 | 8 | |g volume:147 |g year:2023 |g day:20 |g month:05 |g pages:104480 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.mvr.2023.104480 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 147 |j 2023 |b 20 |c 05 |h 104480 |